Category:
Chiral Intermediates
CAS NO:
204656-20-2
Standard:
In-house Standards,
Pharmaceutical intermediates
Liraglutide is a GLP-1 receptor agonist manufactured via solid-phase peptide synthesis. Its molecular formula is C51H74N10O16 (CAS: 204616-60-2), featuring a fatty acid side chain for albumin binding.
Strictly contraindicated in patients with personal or family history of medullary thyroid carcinoma. Store lyophilized powder at -20°C; reconstituted solutions require refrigeration and immediate use to maintain stability.